Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective TrialAdvances in Radiation Oncology.  4:90-95. 2019
2017 Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancerUrologic Oncology: Seminars and Original Investigations.  35:663.e15-663.e21. 2017
2017 Hepatobiliary cancers, version 1.2017 featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  15:563-573. 2017
2017 NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017.Journal of the National Comprehensive Cancer Network.  15:563-573. 2017
2016 Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.American Surgeon.  82:1133-1139. 2016
2016 Improved postoperative survival for intraductal- growth subtype of intrahepatic cholangiocarcinomaAmerican Surgeon.  82:1133-1139. 2016
2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinomaHPB.  18:843-850. 2016
2016 Protocol RAD 0902: A Pilot Study of Transarterial Chemoembolization Followed by Stereotactic Radiation Therapy for Locally Advanced Hepatocellular Carcinoma.International Journal of Radiation Oncology - Biology - Physics.  96:S143. 2016
2016 Successful hepatocellular carcinoma downstaging with transarterial chemoembolization followed by stereotactic radiotherapyLiver Transplantation and Surgery.  22:547-551. 2016
2016 Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignanciesWorld Journal of Gastroenterology.  22:3006-3014. 2016
2016 Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high-grade prostate adenocarcinomaProstate Cancer.  2016. 2016
2015 Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy AloneJournal of Gastrointestinal Cancer.  46:149-155. 2015
2015 Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cmHPB.  17:140-149. 2015
2015 Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinomaJournal of Solid Tumors.  5:59-68. 2015
2014 Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapyRadiation Oncology.  9. 2014
2014 A technique using 99mTc-mebrofenin SPECT for radiotherapy treatment planning for liver cancers or metastasesMedical Dosimetry.  39:7-11. 2014
2014 PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalationUrologic Oncology: Seminars and Original Investigations.  32:687-693. 2014
2014 Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyUrology.  84:1383-1388. 2014
2013 Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancerActa Oncologica.  52:1181-1188. 2013
2013 Patient benefit from salvage radiation for prostate cancer.Journal of Clinical Oncology.  31:175. 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapyJournal of Applied Clinical Medical Physics.  14:4126. 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapyJournal of Applied Clinical Medical Physics.  14:64-71. 2013
2013 Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.ISRN Oncology.  2013:941269. 2013
2012 Radiation necrosis in the brain: Imaging features and differentiation from tumor recurrenceRadiographics.  32:1343-1359. 2012
2012 Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.Prostate Cancer.  2012:546794. 2012
2011 Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.Journal of Clinical Oncology.  29:85. 2011
2010 The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: A case seriesEndoscopy.  42:423-425. 2010
2003 Yttrium90 synovectomy in the management of chronic knee arthritis: a single institution experience.Rheumatology International.  23:216-220. 2003
2003 Case report: Squamous carcinoma in an oesophageal foregut cyst.British Journal of Radiology.  76:343-346. 2003
2002 Oligodendroglioma: clinical profile and treatment results.Neurology India.  50:462-466. 2002
2001 Haemangiopericytoma diagnosed from a metastasis 11years after surgery for "atypical meningioma".British Journal of Radiology.  74:856-858. 2001
2000 Profile of pediatric malignancies: a ten year study.Indian Pediatrics.  37:1234-1238. 2000
1999 60 Gy isodose volumes in carcinoma of the cervix and their relation to the geometry of uterine tube and ovoids.British Journal of Radiology.  72:168-172. 1999
1999 Hyper-fractionated radiotherapy for soft tissue sarcoma: results of the second study of hyper-fractionated radiotherapy.Sarcoma.  3:157-165. 1999
1998 Extragonadal germ-cell tumors: a ten-year experience.American Journal of Clinical Oncology.  21:198-202. 1998
1998 Extraskeletal osteosarcoma of the orbit.Sarcoma.  2:121-124. 1998
1997 Radiotherapy in the treatment of verrucous carcinoma of the oral cavity.Oral Oncology.  33:124-128. 1997
1997 Primary malignant germ cell tumours of the mediastinum--results of multimodality treatment.Acta Oncologica.  36:317-321. 1997
1996 Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer.European journal of cancer. Part B, Oral oncology.  32B:373-376. 1996

Education And Training

  • Doctor of Medicine, University of Kerala 1988
  • Velindre & Singleton NHS Trust, Residency 2004
  • Velindre & Singleton NHS Trust, Residency 2002
  • Royal Marsden Hospital NHS Trust, Residency 1999
  • Regional Cancer Center, Residency 1993
  • Fox Chase Cancer Center, Postdoctoral Fellowship 2004
  • Fox Chase Cancer Center, PA, Postdoctoral Fellowship 2004
  • Full Name

  • Rojymon Jacob